Search
for
Sort by
Research 811–840 of 1000+
- A Subset of TREM2+ Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth
- Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study
- Tofacitinib in alopecia areata and HIV: A curious intersection of immunomodulation, hair regrowth, and hypertrichosis
- Successful treatment of alopecia universalis with abrocitinib: a case report
- Delayed granulomatous eruption of the nose associated with ruxolitinib
- Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
- Pathophysiology of Alopecia Areata in the Pediatric Patient
- Clinical Outcomes of Ritlecitinib in Treatment-Refractory Alopecia Areata: A Single-Center Real-World Study
- Treatment of Frontal Fibrosing Alopecia and Lichen Planopilaris
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Down‐regulation of Shh in the hair follicles of mice during chemotherapy‐induced hair loss is mediated by the JAK / STAT1 signaling pathway
- A Comprehensive Review on Skin Pigmentation-Types, Causes, and Treatment
- Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways
- Review of Promising Off-Label Use of Deucravacitinib
- Revolutionary Approaches to Hair Regrowth: Follicle Neogenesis, Wnt/ß-Catenin Signaling, and Emerging Therapies
- Abrocitinib in the Treatment of Severe Alopecia Areata in a Pediatric Patient: A Case Report
- Seborrheic Dermatitis Revisited: Pathophysiology, Diagnosis, and Emerging Therapies—A Narrative Review
- Recent Advances in Drug Development for Hair Loss
- Pathogenesis and regenerative therapy in vitiligo and alopecia areata: focus on hair follicle
- Frontal fibrosing alopecia: An update on the hypothesis of pathogenesis and treatment
- Molecular Predictors of Ritlecitinib Efficacy in Alopecia Areata: Role of JAK3-Dependent Inflammation and Follicular Integrity
- Efficacy of Barictinib As Compared to Conventional Therapy as a Treatment for Alopecia Areata
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Vitiligo—Current Treatment Options and Future Perspectives
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review
- JAK1 gain-of-function variant causes alopecia areata, atopic dermatitis, and autoimmune thyroid disease
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology
- Poly-D,L-Lactic Acid Filler Increases Hair Growth by Modulating Hair Follicular Stem Cells in Aged Skin